171 related articles for article (PubMed ID: 11423261)
1. Clinical aspects and management of AIDS-related lymphoma.
Sparano JA
Eur J Cancer; 2001 Jul; 37(10):1296-305. PubMed ID: 11423261
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
3. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated lymphomas.
Straus DJ
Curr Oncol Rep; 2001 May; 3(3):260-5. PubMed ID: 11296137
[TBL] [Abstract][Full Text] [Related]
5. Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy.
Thirlwell C; Sarker D; Stebbing J; Bower M
Clin Lymphoma; 2003 Sep; 4(2):86-92. PubMed ID: 14556679
[TBL] [Abstract][Full Text] [Related]
6. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
7. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
8. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
Ratner L; Lee J; Tang S; Redden D; Hamzeh F; Herndier B; Scadden D; Kaplan L; Ambinder R; Levine A; Harrington W; Grochow L; Flexner C; Tan B; Straus D;
J Clin Oncol; 2001 Apr; 19(8):2171-8. PubMed ID: 11304769
[TBL] [Abstract][Full Text] [Related]
10. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
Palmieri C; Treibel T; Large O; Bower M
QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
[TBL] [Abstract][Full Text] [Related]
11. Interventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma.
Martí-Carvajal AJ; Cardona AF; Lawrence A
Cochrane Database Syst Rev; 2009 Jul; (3):CD005419. PubMed ID: 19588373
[TBL] [Abstract][Full Text] [Related]
12. AIDS and cancer in the era of highly active antiretroviral therapy (HAART).
Rabkin CS
Eur J Cancer; 2001 Jul; 37(10):1316-9. PubMed ID: 11423263
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma.
Diamond C; Taylor TH; Im T; Miradi M; Wallace M; Anton-Culver H
Curr HIV Res; 2006 Jul; 4(3):375-8. PubMed ID: 16842088
[TBL] [Abstract][Full Text] [Related]
14. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
González-Aguilar A; Soto-Hernández JL
Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
[TBL] [Abstract][Full Text] [Related]
15. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option.
Klepfish A; Schattner A; Shvidel L; Shtalrid M; Haran M; Bentwich Z; Berrebi A
Leuk Lymphoma; 2003 Feb; 44(2):349-51. PubMed ID: 12688356
[TBL] [Abstract][Full Text] [Related]
17. The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era?
Clayton A; Mughal T
Hematol Oncol; 2004 Sep; 22(3):111-20. PubMed ID: 15991221
[TBL] [Abstract][Full Text] [Related]
18. Impact of HAART on the clinical management of AIDS-related cancers.
Tirelli U; Bernardi D
Eur J Cancer; 2001 Jul; 37(10):1320-4. PubMed ID: 11423264
[TBL] [Abstract][Full Text] [Related]
19. The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Marvin V; Bower M
Cancer Treat Rev; 2004 May; 30(3):249-53. PubMed ID: 15059648
[TBL] [Abstract][Full Text] [Related]
20. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
